7/20 #TumorBoardTuesday

💡Mini tweetorial 4

📚TITAN trial
Pts: met castration sensitive PCa
ADT vs ADT + apalutamide
Including both low and high burden of disease
Median OS: 52.2 months w/o apa vs Not Reached w/ apa 👏
#TumorBoardTuesday